About SISCAPA Assay Technologies
SISCAPA Assay Technologies is a private company based in Washington, District of Columbia. It has reported $3,561,940 raised in three offerings on Form D since August 2012. Its chief executive is Norman Anderson.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Apr 29, 2025 | Aug 28, 2025 | $1,999,940fully sold | 1 | $1.9M | EquityRule 506(b) | Form D ↗ |
| Apr 11, 2014 | Apr 11, 2014 | $1,000,000fully sold | 8 | $125K | EquityRule 506(b) | Form D ↗ |
| Aug 13, 2012 | Aug 23, 2012 | $562,000of $1.5M target | 6 | $93,667 | Equity06 | Form D ↗ |
| Total, three offerings | $3,561,940 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on SISCAPA Assay Technologies's Form D filed Aug 28, 2025.
CS
Constance Seniff
Secretary, Treasurer and director
TP
Terry Pearson
Director
NA
Norman Anderson
President, CEO and director
GS
Gus Salem
Director
Earlier filings also listed N. Anderson (president and ceo, director, last listed Apr 2014) and Guo-Liang Yu (director, last listed Apr 2014).